ARTESE, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 683
EU - Europa 137
AS - Asia 35
OC - Oceania 5
SA - Sud America 4
Totale 864
Nazione #
US - Stati Uniti d'America 683
IE - Irlanda 34
IT - Italia 30
DE - Germania 23
UA - Ucraina 11
GB - Regno Unito 9
IR - Iran 9
SE - Svezia 8
CN - Cina 7
BE - Belgio 6
VN - Vietnam 5
FI - Finlandia 4
FR - Francia 3
HK - Hong Kong 3
NZ - Nuova Zelanda 3
AU - Australia 2
BR - Brasile 2
ES - Italia 2
JP - Giappone 2
KR - Corea 2
MY - Malesia 2
NL - Olanda 2
PL - Polonia 2
RU - Federazione Russa 2
SG - Singapore 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CL - Cile 1
GR - Grecia 1
IN - India 1
TR - Turchia 1
Totale 864
Città #
Wilmington 204
Woodbridge 127
Houston 91
Chandler 53
Fairfield 40
Ann Arbor 22
Ashburn 19
Dublin 19
New York 13
Rome 12
Seattle 12
Medford 10
Jacksonville 9
Cambridge 7
Brussels 6
Cagliari 5
Lawrence 5
Palo Alto 5
Redwood City 4
Auckland 3
Beijing 3
Croydon 3
Dearborn 3
Dong Ket 3
Zhengzhou 3
Cedarhurst 2
Creede 2
Hanoi 2
Helsinki 2
Hong Kong 2
Kuala Lumpur 2
London 2
Menlo Park 2
Milan 2
Mülheim 2
Norwalk 2
Philadelphia 2
San Francisco 2
Santa Clara 2
São Paulo 2
A Coruña 1
Albano Laziale 1
Amsterdam 1
Canberra 1
Cascina 1
Central District 1
Dipignano 1
Dubai 1
Falls Church 1
Kraków 1
Kunming 1
La Plata 1
Los Angeles 1
Manitou Springs 1
Monza 1
Mountain View 1
Osaka 1
Perugia 1
Phoenix 1
Rotterdam 1
San Diego 1
San Giorgio A Cremano 1
San Mateo 1
Singapore 1
Stockholm 1
Sydney 1
University Park 1
Warsaw 1
Totale 739
Nome #
Effect of maraviroc on non-R5 tropic HIV-1: Refined analysis of subjects from the phase IIb study A4001029 409
New resistance mutations to nucleoside reverse transcriptase inhibitors at codon 184 of HIV-1 reverse transcriptase (M184L and M184T) 169
Computational studies of mutations associated to resistance in HIV-1 macromolecular targets and implications in rational design of novel antiviral agents 102
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses 89
Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control 64
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile 25
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses 19
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 6
Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an In Silico Drug Repurposing Approach 4
Totale 887
Categoria #
all - tutte 2.829
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.829


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201923 0 0 0 0 0 0 0 0 0 0 12 11
2019/2020191 10 7 20 17 18 22 24 16 16 15 10 16
2020/2021171 12 14 9 15 12 13 46 25 5 5 8 7
2021/202295 1 8 0 10 5 5 16 11 14 6 4 15
2022/2023147 32 13 5 18 9 22 9 15 14 2 5 3
2023/202462 5 1 4 2 3 13 5 13 12 2 2 0
Totale 887